VaxGen Inc. (VXGN)

SIC:
PHARMACEUTICAL PREPARATIONS
1000 MARINA BLVD BRISBANE, CA 94005
View SEC Filings from VXGN instead.

View recent insider trading info

Funds Holding VXGN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VXGN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Events (8k)

  • 8-K: filed on 2016-04-18:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-01:
    Item 9.01: Financial Statements and Exhibits
    Item 4.01: Changes in Registrant's Certifying Accountant
  • 8-K: filed on 2016-03-29:
    Item 9.01: Financial Statements and Exhibits
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2016-03-18:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2016-04-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SULAT JAMES R

    • Director
    0 2015-07-15 0

    DREXLER KAREN

    • Director
    0 2015-07-15 0

    CURNUTTE JOHN T

    • Director
    0 2015-07-15 0

    SPERZEL JOHN J III

    • Director
    0 2015-07-15 0

    HUTT POLLARD ELIZABETH ANN

    • Director
    0 2015-07-15 0

    RAFIELD LORI F PHD CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    0 2015-06-30 0

    PATTERSON LEONE D CHIEF FINANCIAL OFFICER

    • Officer
    0 2015-03-20 0

    FANG KENNETH C. CHIEF MEDICAL OFFICER

    • Officer
    0 2014-12-16 0

    JOHNSON ALEXANDER L PRESIDENT

    • Officer
    0 2014-08-15 0

    PANEK JAMES P

    • Director
    0 2014-05-29 0

    OLUKOTUN ADEOYE Y

    • Director
    0 2014-05-29 0

    PATRICK CHARLES W

    • Director
    0 2014-05-29 0

    GALLIGAN ANDREW H

    • Director
    0 2014-05-29 0

    VIRET JEAN-FREDERIC CHIEF FINANCIAL OFFICER

    • Officer
    4,648 2014-04-28 0

    ZYCHLINSKY BULAEVSKY EMILIA CHIEF TECHNICAL OFFICER

    • Officer
    22,500 2013-12-04 0

    BURRILL LIFE SCIENCES CAPITAL FUND LP

    BURRILL INDIANA LIFE SCIENCES CAPITAL FUND, L.P.

    BURRILL & CO (LIFE SCIENCES GP), LLC

    BURRILL & CO (INDIANA GP), LLC

    BURRILL & CO LLC

    BURRILL STEVEN

    • 10% Owner
    No longer subject to file 2013-10-30 0

    RICHEY ROBERT MICHAEL CHIEF BUSINESS OFFICER

    • Officer
    111,542 2013-09-03 0

    WARD BRIAN E. PRESIDENT AND CEO

    • Officer
    • Director
    110,000 2012-08-31 0

    BAKER BROS. CAPITAL (GP), LLC

    BAKER FELIX

    BAKER JULIAN

    • 10% Owner
    0 2012-01-27 0

    ALFANO BERNARD M. (DINO) EXECUTIVE VICE PRESIDENT & CCO

    • Officer
    0 2011-08-10 0

    BOCK LOUIS C

    • Director
    0 2010-07-29 0

    FOSTER DAVID J EXE. VP, CFO AND SECRETARY

    • Officer
    209,343 2010-07-28 0

    BAKER JULIAN

    • 10% Owner
    57,630 2010-07-28 0

    BAKER BIOTECH CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • 10% Owner
    2,306,025 2010-07-28 0

    BAKER BROTHERS LIFE SCIENCES CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • 10% Owner
    4,567,055 2010-07-28 0

    14159 CAPITAL (GP), LLC

    BAKER JULIAN

    BAKER FELIX

    • 10% Owner
    140,525 2010-07-28 0

    BAKER FELIX

    • 10% Owner
    57,631 2010-07-28 0

    WOLFERT ROBERT L EXECUTIVE VP AND CSO

    • Officer
    0 2010-07-28 0

    PLEWMAN PATRICK PRESIDENT AND CEO

    • Officer
    • Director
    0 2010-07-28 0

    ROI CAPITAL MANAGEMENT INC

    BOYER MARK THOMAS

    SOBOLESKI MITCHELL JOSEPH

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    No longer subject to file 2009-10-19 0

    BA VALUE INVESTORS, LLC

    BRONSON STEVEN N

    • 10% Owner
    1,822,000 2009-08-21 0

    BERGER FRANKLIN M

    • Director
    0 2008-06-09 0

    REILLY KEVIN LEO

    • Director
    0 2008-06-09 0

    DESTEFANO PAUL

    • Director
    0 2008-06-09 0

    PFEFFER MATTHEW J SENIOR VICE PRESIDENT AND CFO

    • Officer
    20,000 2007-12-04 0

    WHITEHEAD PIERS C VICE PRESIDENT

    • Officer
    30,323 2007-12-04 0

    CAUDILL RANDALL L W

    • Director
    • CHAIRMAN OF THE BOARD
    22,000 2007-11-16 0

    GURWITH MARC J SENIOR VICE PRESIDENT

    • Officer
    23,620 2007-11-15 0

    GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

    • 10% Owner
    4,522,019 2007-11-13 0

    ANTHONY JACK M

    • Director
    0 2007-05-18 0

    IGNON R LANCE VICE PRESIDENT

    • Officer
    388,925 2007-02-12 0

    GRECO MICHEL DIRECTOR

    • Director
    35,000 2007-02-12 0

    SLATER EVE ELIZABETH DIRECTOR

    • Director
    47,500 2007-02-12 0

    LEVINE MYRON M DIRECTOR

    • Director
    35,000 2007-02-12 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments